Skandinaviska Enskilda Banken (SEB)’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $251K | Sell |
4,142
-3,991,313
| -100% | -$233M | 0.01% | 149 |
|
|
2025
Q4 | $216M | Buy |
3,995,455
+275,468
| +7% | +$13.3M | 0.86% | 19 |
|
|
2025
Q3 | $168M | Buy |
3,719,987
+1,393,646
| +60% | +$65.1M | 0.67% | 24 |
|
|
2025
Q2 | $108M | Buy |
2,326,341
+1,013,851
| +77% | +$49.8M | 0.47% | 39 |
|
|
2025
Q1 | $80M | Sell |
1,312,490
-44,816
| -3% | -$2.61M | 0.39% | 47 |
|
|
2024
Q4 | $76.1M | Buy |
1,357,306
+856,640
| +171% | +$47.9M | 0.34% | 51 |
|
|
2024
Q3 | $25.9M | Sell |
500,666
-864,618
| -63% | -$40.6M | 0.12% | 146 |
|
|
2024
Q2 | $56.7M | Buy |
1,365,284
+935,273
| +217% | +$41.8M | 0.27% | 68 |
|
|
2024
Q1 | $23.3M | Sell |
430,011
-5,206
| -1% | -$265K | 0.11% | 167 |
|
|
2023
Q4 | $22.3M | Buy |
435,217
+1,423
| +0.3% | +$74.7K | 0.13% | 152 |
|
|
2023
Q3 | $25.2M | Sell |
433,794
-197,018
| -31% | -$12.1M | 0.17% | 124 |
|
|
2023
Q2 | $40.3M | Sell |
630,812
-321,089
| -34% | -$21.5M | 0.26% | 78 |
|
|
2023
Q1 | $66M | Buy |
951,901
+9,321
| +1% | +$657K | 0.46% | 46 |
|
|
2022
Q4 | $67.8M | Sell |
942,580
-33,273
| -3% | -$2.51M | 0.51% | 38 |
|
|
2022
Q3 | $69.4M | Sell |
975,853
-199,157
| -17% | -$14.4M | 0.54% | 43 |
|
|
2022
Q2 | $90.5M | Sell |
1,175,010
-362,178
| -24% | -$27.6M | 0.67% | 28 |
|
|
2022
Q1 | $112M | Sell |
1,537,188
-234,330
| -13% | -$15.7M | 0.66% | 25 |
|
|
2021
Q4 | $111M | Sell |
1,771,518
-98,711
| -5% | -$5.79M | 0.57% | 36 |
|
|
2021
Q3 | $111M | Sell |
1,870,229
-295,761
| -14% | -$19.5M | 0.61% | 30 |
|
|
2021
Q2 | $145M | Buy |
2,165,990
+315,101
| +17% | +$20.5M | 0.89% | 16 |
|
|
2021
Q1 | $117M | Buy |
1,850,889
+832,407
| +82% | +$51.8M | 0.77% | 22 |
|
|
2020
Q4 | $63.2M | Sell |
1,018,482
-805,235
| -44% | -$49.5M | 0.43% | 51 |
|
|
2020
Q3 | $110M | Sell |
1,823,717
-925,004
| -34% | -$55.7M | 0.8% | 20 |
|
|
2020
Q2 | $162M | Sell |
2,748,721
-249,140
| -8% | -$14.9M | 1.31% | 10 |
|
|
2020
Q1 | $167M | Sell |
2,997,861
-740,037
| -20% | -$45.2M | 1.69% | 7 |
|
|
2019
Q4 | $240M | Buy |
3,737,898
+463,099
| +14% | +$26.5M | 1.89% | 4 |
|
|
2019
Q3 | $166M | Buy |
3,274,799
+425,799
| +15% | +$20M | 1.4% | 12 |
|
|
2019
Q2 | $129M | Buy |
2,849,000
+448,994
| +19% | +$20.9M | 1.11% | 20 |
|
|
2019
Q1 | $115M | Buy |
2,400,006
+1,521,399
| +173% | +$75.8M | 1.05% | 22 |
|
|
2018
Q4 | $45.7M | Buy |
878,607
+382,196
| +77% | +$20.5M | 0.41% | 54 |
|
|
2018
Q3 | $30.8M | Buy |
496,411
+212,091
| +75% | +$12.6M | 0.23% | 93 |
|
|
2018
Q2 | $15.7M | Buy |
284,320
+91,286
| +47% | +$4.93M | 0.13% | 128 |
|
|
2018
Q1 | $12.2M | Sell |
193,034
-1,419,631
| -88% | -$91.3M | 0.12% | 129 |
|
|
2017
Q4 | $98.8M | Buy |
1,612,665
+129,984
| +9% | +$8.13M | 0.85% | 31 |
|
|
2017
Q3 | $94.5M | Sell |
1,482,681
-93,200
| -6% | -$5.44M | 0.86% | 27 |
|
|
2017
Q2 | $87.8M | Buy |
1,575,881
+1,290,070
| +451% | +$70.2M | 0.84% | 26 |
|
|
2017
Q1 | $15.5M | Buy |
285,811
+17
| +0% | +$932 | 0.16% | 120 |
|
|
2016
Q4 | $16.7M | Sell |
285,794
-3,086
| -1% | -$169K | 0.2% | 87 |
|
|
2016
Q3 | $15.6M | Buy |
288,880
+5,600
| +2% | +$360K | 0.17% | 103 |
|
|
2016
Q2 | $20.8M | Buy |
283,280
+13,650
| +5% | +$965K | 0.23% | 82 |
|
|
2016
Q1 | $17.2M | Sell |
269,630
-4,670
| -2% | -$295K | 0.19% | 91 |
|
|
2015
Q4 | $18.9M | Buy |
+274,300
| New | +$18.1M | 0.24% | 79 |
|
Other funds holding BMY
VCM
VPM
Skandinaviska Enskilda Banken (SEB)'s BMY Position: Q1 2026 in Review
Skandinaviska Enskilda Banken (SEB) reduced its Bristol-Myers Squibb (BMY) stake by 100% in Q1 2026, selling an estimated $233M and leaving 4,142 shares worth $251K. The position accounts for 0.01% of the portfolio, ranked #149.
Skandinaviska Enskilda Banken (SEB) first reported a position in BMY in Q4 2015 and has held it in 42 quarters since. The position peaked at $240M in Q4 2019. 2,526 funds tracked by Wall St. Rank hold BMY as of Q1 2026.
- Skandinaviska Enskilda Banken (SEB) held 4,142 shares of Bristol-Myers Squibb worth $251K as of Q1 2026.
- Skandinaviska Enskilda Banken (SEB) sold 3,991,313 Bristol-Myers Squibb shares in Q1 2026, an estimated $233M.
- Bristol-Myers Squibb made up 0.01% of Skandinaviska Enskilda Banken (SEB)'s portfolio in Q1 2026, its #149 holding.
- Skandinaviska Enskilda Banken (SEB) first reported a position in Bristol-Myers Squibb in Q4 2015 and has held it in 42 quarters since.
- Skandinaviska Enskilda Banken (SEB)'s Bristol-Myers Squibb position peaked at $240M in Q4 2019.
- 2,526 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q1 2026.
Based on Skandinaviska Enskilda Banken (SEB)'s 13F filing for Q1 2026, filed 15 May 2026.